News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
294 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17773)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Genetown
Nitto Avecia Completes Multiple Successful Oligonucleotide Manufacturing Synthesis Runs at 1.6 Mol Scale
This exciting news comes only months after bringing into operation Avecia’s new API manufacturing synthesis capabilities.
November 7, 2017
·
1 min read
FDA
Genentech’s Frontline Alecensa Approved for Non-Small Cell Lung Cancer
Phase III data showed Alecensa extended the average time that people lived without their disease worsening compared to crizotinib.
November 7, 2017
·
12 min read
Policy
Axonics Receives IDE Clearance From U.S. FDA to Conduct a Pivotal Study With Its Sacral Neuromodulation System for the Treatment of Urinary Dysfunction
Axonics announced the U.S. Food & Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) in accordance with 21 CFR 812 regulations allowing Axonics to conduct a pivotal study designed to gain FDA approval in the United States.
November 7, 2017
·
3 min read
Business
Veracyte Announces Third Quarter 2017 Financial Results
For the third quarter of 2017, revenue was $17.5 million, compared to $18.6 million for the third quarter of 2016.
November 7, 2017
·
12 min read
Business
ERYTECH Reports Third Quarter 2017 Financial Results and Provides Business Update
Net loss for the nine-month period ended September 30, 2017 was €20.8 million, compared to €16.1 million for the same period in the prior year.
November 7, 2017
·
13 min read
BioMidwest
Symphony Clinical Research Earns WBENC Distinction for Fourth Consecutive Year
Symphony Clinical Research received national re-certification as a Women’s Business Enterprise by the Women’s Business Development Center-Chicago, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC).
November 7, 2017
·
2 min read
Pharm Country
Merck Animal Health Introduces Care & Control of Pet Diabetes to Help Pet Owners Deal With the Disease
Merck Animal Health has launched Care & Control of Pet Diabetes Featuring Sugar & Spike, a global educational program to provide pet owners with the tools they need to help manage their pets’ diabetes.
November 7, 2017
·
6 min read
Drug Development
FDA Lifts Clinical Hold on Cellectis Phase 1 Clinical Trials With UCART123 in AML and BPDCN
Cellectis is currently working with the investigators and clinical sites to obtain IRB’s approval on the revised protocols and resume patient enrollment.
November 7, 2017
·
4 min read
Sectra Launches Vendor-Neutral Integration for Machine Learning Applications - Speeds Up Access to New Technology in Healthcare
Sectra is launching vendor-neutral access to machine learning in its enterprise imaging platform.
November 7, 2017
·
2 min read
Business
DermTech Announces Addition of Harold Rabinovitz to Scientific Advisory Board
He is world-renown for his work in dermoscopy and confocal microscopy.
November 7, 2017
·
1 min read
Previous
3 of 30
Next